These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3304476)

  • 21. Prognostic value of DNA ploidy in breast cancer stage I-II.
    Cufer T; Lamovec J; Bracko M; Lindtner J; Us-Krasovec M
    Neoplasma; 1997; 44(2):127-32. PubMed ID: 9201293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
    Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
    Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Nuclear DNA content in breast cancer--relation between ploidy and lymph node metastasis].
    Nishi T; Okajima K; Fujiwara A; Yasuda M; Yamada S; Taguchi T; Sekimoto T
    Nihon Gan Chiryo Gakkai Shi; 1986 Feb; 21(1):103-7. PubMed ID: 3701162
    [No Abstract]   [Full Text] [Related]  

  • 24. Prognostic significance of flow cytometric DNA analysis in node-negative breast cancer patients.
    Lewis WE
    Cancer; 1990 May; 65(10):2315-20. PubMed ID: 2346915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognostic significance of nuclear DNA content in breast cancer].
    Nishi T; Okajima K; Taguchi T; Ryo T; Mizutani H; Kawashima Y; Sekimoto T
    Nihon Gan Chiryo Gakkai Shi; 1990 Mar; 25(3):569-77. PubMed ID: 2351850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study.
    Susini T; Olivieri S; Molino C; Amunni G; Rapi S; Taddei G; Scarselli G
    Int J Gynecol Cancer; 2011 May; 21(4):678-84. PubMed ID: 21412157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancer.
    Stål O; Wingren S; Carstensen J; Rutqvist LE; Skoog L; Klintenberg C; Nordenskjöld B
    Eur J Cancer Clin Oncol; 1989 Feb; 25(2):301-9. PubMed ID: 2702984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for short-term prognosis in breast cancer.
    Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
    Anticancer Res; 1997; 17(4B):3091-7. PubMed ID: 9329609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of morphometry and DNA flow-cytometry features of invasive breast cancers detected by population screening: comparison with control group of hospital patients.
    Uyterlinde AM; Baak JP; Schipper NW; Peterse HJ; Meijer JW; Vooys PG; Matze E
    Int J Cancer; 1991 May; 48(2):173-81. PubMed ID: 2019464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Epithelial growth factor receptors (EGF-R) and DNA flow cytometry in addition to lymph node and hormone receptor status as prognostic factors in primary breast cancer].
    Costa SD; Kaufmann M; Fabbro D; Tokus M; Feichter G; Klinga K; Bastert G
    Geburtshilfe Frauenheilkd; 1989 Apr; 49(4):375-8. PubMed ID: 2544476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
    Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential determination of immunocytochemical estrogen receptor and nuclear DNA content in fine needle biopsies from breast carcinoma.
    Pestana CB; Donozo N; Pinto AJ; de Almeida PC; Machado-Santelli GM
    Breast Cancer Res Treat; 1991 Sep; 19(1):39-46. PubMed ID: 1756266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peritumoral lymphatic vessel invasion compared with DNA ploidy, proliferative activity, and other pathologic features as prognostic indicators in operable breast cancer.
    Gasparini G; Meli S; Panizzoni GA; Visonà A; Boracchi P; Bevilacqua P; Marubini E; Pozza F
    Breast Cancer Res Treat; 1992 Mar; 20(3):195-204. PubMed ID: 1571572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
    Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
    Anticancer Res; 1997; 17(2B):1417-23. PubMed ID: 9137508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Malignancy grading in breast cancer as assessed by nuclear DNA content].
    Nishi T; Okajima K; Taguchi T; Mizutani H; Sogabe T; Uragami I; Sekimoto T
    Nihon Geka Gakkai Zasshi; 1988 Apr; 89(4):576-81. PubMed ID: 3405196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of DNA ploidy, cell kinetics, estrogen receptor and clinical status in patients with breast cancer.
    Kuo SH; Lin CC; Yu SC; Liaw KY; Wei TC; Chen KM
    Taiwan Yi Xue Hui Za Zhi; 1985 Nov; 84(11):1260-9. PubMed ID: 3868701
    [No Abstract]   [Full Text] [Related]  

  • 37. DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients.
    Wenger CR; Beardslee S; Owens MA; Pounds G; Oldaker T; Vendely P; Pandian MR; Harrington D; Clark GM; McGuire WL
    Breast Cancer Res Treat; 1993 Oct; 28(1):9-20. PubMed ID: 8123871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA ploidy and percent S-phase as prognostic factors in node-positive breast cancer: results from patients enrolled in two prospective randomized trials.
    Witzig TE; Ingle JN; Schaid DJ; Wold LE; Barlow JF; Gonchoroff NJ; Gerstner JB; Krook JE; Grant CS; Katzmann JA
    J Clin Oncol; 1993 Feb; 11(2):351-9. PubMed ID: 8426213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytophotometric estimation of cell proliferation in breast cancer. Correlation to the clinical course during long-term follow-up.
    Hatschek T; Bjelkenkrantz K; Carstensen J; Nordenskjöld B; Nordin B; Stål O; Stenkvist B
    Acta Oncol; 1989; 28(6):801-6. PubMed ID: 2611033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of DNA stemline and cell kinetics between primary breast cancer and its lymph node metastasis.
    Chang DB; Yang PC; Chang KJ; Luh KT; Kuo SH
    Anal Quant Cytol Histol; 1993 Feb; 15(1):32-8. PubMed ID: 8385953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.